Department of Surgery
USF Health · College of Medicine

Jorge E. Marcet, MD

Professor of Surgery, USF

Address:
1 Tampa General Circle
Suite F-145
Tampa, Fl 33606 
(813) 844-4545
jmarcet@hsc.usf.edu 

Education:
M.D. Cornell University
Internships, St. Luke's/Roosevelt Hospital Center, NY
Residencies, St. Luke's/Roosevelt Hospital Center, NY
Fellowships, St. Luke's/Roosevelt Hospital Center

Area of Expertise 
• Surgical Treatment of Colon & Rectal Cancer
• Ulcerative Colitis Crohn's Diesease
• Anorectal Reconstruction

Publications:
Marcet J, Nord J: Colon and Rectal Obstruction, In: Diseases of the Colon, Eds. S. Wexner and N. Stollman. In press.

Durkin A, Marcet J: Anal Cancer. In: Pocket Oncology, Eds. Zervos E and Goldin S. In press.

Moreira SG, Seigne JD, Ordorica RC, Marcet JE, Lockhart JL: Devastating Complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int 2004; 93(1): 31-35.

Sung J, Wessel M, Gallagher S, Marcet J, Murr M: Failure of Medicare Health Maintenance Organizations to Control the Cost of Colon Resections in Elderly Patients. Arch Surg, Dec 2004; 139: 1366 - 1370.

Nasir A, Boulware D, Kaiser H, Bodey B, Siegel S, Crawley S, Yeatman T, Marcet J, Coppola D: Flat and polypoid adenocarcinomas of the colorectum: a comparative histomorphologic analysis of 47 cases. Human Path 2004; 35(5):604-611.

Marcet J, Karl R: Local Excision for Rectal Tumors. In: Advances in Surgery, vol. 36, Ed JL Cameron, Mosby, 2003.

Current Research:

  1. Ulcerative Colitis:
    A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the
    Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Ulcerative Colitis.

    A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of
    Vedolizumab (MLN0002) in Patients with Ulcerative Colitis (UC) and Crohn’s Disease (CD)
  2. Crohn’s Disease:
    A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the
    Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Crohn’s Disease
  3. Colorectal Cancer:
    Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Previously Untreated Patients with Metastatic Colorectal Adenocarcinoma

    A Phase III Prospective Randomized Trial Comparing
    Laparoscopic-assisted Resection Versus Open Resection for Rectal
    Cancer

    TIMING OF RECTAL CANCER RESPONSE TO CHEMORADIATION
  4. Surgical Site Infections:
    A Randomized Controlled Clinical Trial Evaluating the Efficacy of Silverlon in Preventing Surgical Site Infection after Colorectal Surgery
  5. Post Operative Pain Management:
    Bupivacaine Effectiveness and Safety in SABER™ Trial (BESST)